Literature DB >> 6655287

Acquired macrophage resistance to in vitro infection with Leishmania.

C B Panosian, D J Wyler.   

Abstract

An important feature of pathogenesis in leishmaniasis is the ability of the intracellular amastigote to gain entry into host mononuclear phagocytes and subsequently replicate. Resident peritoneal macrophages freshly harvested from Leishmania tropica-infected C57B1/6 mice and uninfected controls were therefore compared for their ability to ingest L tropica amastigotes in vitro. Macrophages from infected mice had a strikingly reduced ability to ingest parasites, but they ingested latex beads and IgG-sensitized erythrocytes as well as or more than control macrophages. Preincubation of these macrophages for 24 hr restored the degree of parasite ingestion to control levels. This alteration in macrophage function could be observed as early as two weeks of infection and persisted until spontaneous resolution of the infection occurred at about six weeks. The observations suggest that acquired defense in leishmaniasis may include a specific inhibition of amastigote uptake by host macrophages.

Entities:  

Mesh:

Year:  1983        PMID: 6655287     DOI: 10.1093/infdis/148.6.1049

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  3 in total

1.  Treatment of experimental cutaneous leishmaniasis with liposome-intercalated amphotericin B.

Authors:  C B Panosian; M Barza; F Szoka; D J Wyler
Journal:  Antimicrob Agents Chemother       Date:  1984-05       Impact factor: 5.191

2.  Cell contact-mediated macrophage activation for antileishmanial defence: mapping of the genetic restriction to the I region of the MHC.

Authors:  J P Sypek; D J Wyler
Journal:  Clin Exp Immunol       Date:  1985-12       Impact factor: 4.330

3.  Optimization of the Timing of Induction for the Assessment of Nitric Oxide Production in Leishmania major Infected Macrophage Cells.

Authors:  Somaye Sadeghi; Negar Seyed; Sima Rafati; Tahereh Taheri
Journal:  Iran J Parasitol       Date:  2016 Jul-Sep       Impact factor: 1.012

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.